<bill session="118" type="h" number="1313" updated="2025-11-18T18:37:22Z">
  <state datetime="2023-03-01">REFERRED</state>
  <status>
    <introduced datetime="2023-03-01"/>
  </status>
  <introduced datetime="2023-03-01"/>
  <titles>
    <title type="display">Transparency in CFPB Cost-Benefit Analysis Act</title>
    <title type="short" as="introduced">Transparency in CFPB Cost-Benefit Analysis Act</title>
    <title type="official" as="introduced">To enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001195"/>
  <cosponsors>
    <cosponsor bioguide_id="B001282" joined="2023-03-01"/>
    <cosponsor bioguide_id="D000626" joined="2023-03-01"/>
    <cosponsor bioguide_id="D000594" joined="2023-07-12"/>
    <cosponsor bioguide_id="E000294" joined="2023-03-01"/>
    <cosponsor bioguide_id="F000471" joined="2023-03-01"/>
    <cosponsor bioguide_id="F000474" joined="2023-03-01"/>
    <cosponsor bioguide_id="G000597" joined="2023-03-24"/>
    <cosponsor bioguide_id="H001072" joined="2023-03-09"/>
    <cosponsor bioguide_id="H001093" joined="2023-03-01"/>
    <cosponsor bioguide_id="H001058" joined="2023-03-01"/>
    <cosponsor bioguide_id="K000397" joined="2023-03-01"/>
    <cosponsor bioguide_id="K000392" joined="2023-03-01"/>
    <cosponsor bioguide_id="L000583" joined="2023-03-01"/>
    <cosponsor bioguide_id="L000569" joined="2023-03-01"/>
    <cosponsor bioguide_id="N000190" joined="2023-03-01"/>
    <cosponsor bioguide_id="N000193" joined="2023-03-01"/>
    <cosponsor bioguide_id="O000175" joined="2023-03-01"/>
    <cosponsor bioguide_id="P000599" joined="2023-03-01"/>
    <cosponsor bioguide_id="R000612" joined="2023-03-01"/>
    <cosponsor bioguide_id="S000250" joined="2023-03-01"/>
    <cosponsor bioguide_id="S001213" joined="2023-03-01"/>
    <cosponsor bioguide_id="S001214" joined="2023-03-07"/>
    <cosponsor bioguide_id="W000816" joined="2023-03-01"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-03-01" state="REFERRED">
      <text>Referred to the House Committee on Financial Services.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSBA" name="House Financial Services" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="2798" relation="unknown"/>
    <bill session="118" type="s" number="1362" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Finance and financial sector"/>
  </subjects>
  <amendments/>
  <summary date="2023-05-18T15:50:54Z" status="Introduced in House">Transparency in CFPB Cost-Benefit Analysis Act 

This bill sets forth information required to be included in a rulemaking made by the Consumer Financial Protection Bureau (CFPB). Specifically, the CFPB must publish a justification of the proposed rulemaking; a quantitative and qualitative assessment of all anticipated direct and indirect costs and benefits; alternatives to the proposed rulemaking; impacts on small businesses; and any assumptions, data, or studies used in preparing this information.</summary>
</bill>
